ID   UN13D_HUMAN             Reviewed;        1090 AA.
AC   Q70J99; B4DWG9; Q9H7K5;
DT   16-AUG-2004, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 1.
DT   28-JUN-2023, entry version 156.
DE   RecName: Full=Protein unc-13 homolog D;
DE   AltName: Full=Munc13-4;
GN   Name=UNC13D;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), TISSUE SPECIFICITY, SUBCELLULAR
RP   LOCATION, AND INVOLVEMENT IN FHL3.
RC   TISSUE=Blood;
RX   PubMed=14622600; DOI=10.1016/s0092-8674(03)00855-9;
RA   Feldmann J., Callebaut I., Raposo G., Certain S., Bacq D., Dumont C.,
RA   Lambert N., Ouachee-Chardin M., Chedville G., Tamary H., Minard-Colin V.,
RA   Vilmer E., Blanche S., Le Deist F., Fischer A., de Saint Basile G.;
RT   "Munc13-4 is essential for cytolytic granules fusion and is mutated in a
RT   form of familial hemophagocytic lymphohistiocytosis (FHL3).";
RL   Cell 115:461-473(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Spleen;
RX   PubMed=11214971; DOI=10.1093/dnares/7.6.357;
RA   Hattori A., Okumura K., Nagase T., Kikuno R., Hirosawa M., Ohara O.;
RT   "Characterization of long cDNA clones from human adult spleen.";
RL   DNA Res. 7:357-366(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Synovium;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R., Gnerre S.,
RA   Goldstein S., Grafham D.V., Grocock R., Hafez N., Hagopian D.S., Hart E.,
RA   Norman C.H., Humphray S., Jaffe D.B., Jones M., Kamal M., Khodiyar V.K.,
RA   LaButti K., Laird G., Lehoczky J., Liu X., Lokyitsang T., Loveland J.,
RA   Lui A., Macdonald P., Major J.E., Matthews L., Mauceli E., McCarroll S.A.,
RA   Mihalev A.H., Mudge J., Nguyen C., Nicol R., O'Leary S.B., Osoegawa K.,
RA   Schwartz D.C., Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in the
RT   human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Pancreas;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   FUNCTION, SUBCELLULAR LOCATION, INTERACTION WITH RAB27A, TISSUE
RP   SPECIFICITY, DOMAIN, AND MUTAGENESIS OF 608-VAL--ALA-611.
RX   PubMed=15548590; DOI=10.1091/mbc.e04-10-0923;
RA   Neeft M., Wieffer M., de Jong A.S., Negroiu G., Metz C.H., van Loon A.,
RA   Griffith J., Krijgsveld J., Wulffraat N., Koch H., Heck A.J.R., Brose N.,
RA   Kleijmeer M., van der Sluijs P.;
RT   "Munc13-4 is an effector of rab27a and controls secretion of lysosomes in
RT   hematopoietic cells.";
RL   Mol. Biol. Cell 16:731-741(2005).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein phosphorylation
RT   analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [9]
RP   FUNCTION, SUBCELLULAR LOCATION, INTERACTION WITH RAB27A, AND DOMAIN.
RX   PubMed=17237785; DOI=10.1038/ni1431;
RA   Menager M.M., Menasche G., Romao M., Knapnougel P., Ho C.-H., Garfa M.,
RA   Raposo G., Feldmann J., Fischer A., de Saint Basile G.;
RT   "Secretory cytotoxic granule maturation and exocytosis require the effector
RT   protein hMunc13-4.";
RL   Nat. Immunol. 8:257-267(2007).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-150, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- FUNCTION: Plays a role in cytotoxic granule exocytosis in lymphocytes.
CC       Required for both granule maturation and granule docking and priming at
CC       the immunologic synapse. Regulates assembly of recycling and late
CC       endosomal structures, leading to the formation of an endosomal exocytic
CC       compartment that fuses with perforin-containing granules at the
CC       immunologic synapse and licences them for exocytosis. Regulates Ca(2+)-
CC       dependent secretory lysosome exocytosis in mast cells.
CC       {ECO:0000269|PubMed:15548590, ECO:0000269|PubMed:17237785}.
CC   -!- COFACTOR:
CC       Name=Ca(2+); Xref=ChEBI:CHEBI:29108; Evidence={ECO:0000255|PROSITE-
CC         ProRule:PRU00041};
CC   -!- SUBUNIT: Interacts with DOC2A (By similarity). Interacts with RAB27A.
CC       {ECO:0000250, ECO:0000269|PubMed:15548590,
CC       ECO:0000269|PubMed:17237785}.
CC   -!- INTERACTION:
CC       Q70J99; P51159: RAB27A; NbExp=3; IntAct=EBI-11479429, EBI-716881;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Membrane; Peripheral membrane protein.
CC       Late endosome. Recycling endosome. Lysosome. Note=Colocalizes with
CC       cytotoxic granules at the plasma membrane. Localizes to endosomal
CC       exocytic vesicles.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q70J99-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q70J99-2; Sequence=VSP_011385, VSP_011386, VSP_011387;
CC       Name=3;
CC         IsoId=Q70J99-3; Sequence=VSP_037949;
CC   -!- TISSUE SPECIFICITY: Expressed at high levels in spleen, thymus and
CC       leukocytes. Also expressed in lung and placenta, and at very low levels
CC       in brain, heart, skeletal muscle and kidney. Expressed in cytotoxic T-
CC       lymphocytes (CTL) and mast cells. {ECO:0000269|PubMed:14622600,
CC       ECO:0000269|PubMed:15548590}.
CC   -!- DOMAIN: The MHD1 and MHD2 domains mediate localization on recycling
CC       endosomes and lysosome. {ECO:0000269|PubMed:15548590,
CC       ECO:0000269|PubMed:17237785}.
CC   -!- DISEASE: Hemophagocytic lymphohistiocytosis, familial, 3 (FHL3)
CC       [MIM:608898]: A rare disorder characterized by immune dysregulation
CC       with hypercytokinemia, defective function of natural killer cell, and
CC       massive infiltration of several organs by activated lymphocytes and
CC       macrophages. The clinical features of the disease include fever,
CC       hepatosplenomegaly, cytopenia, and less frequently neurological
CC       abnormalities ranging from irritability and hypotonia to seizures,
CC       cranial nerve deficits and ataxia. {ECO:0000269|PubMed:14622600}.
CC       Note=The disease is caused by variants affecting the gene represented
CC       in this entry.
CC   -!- SIMILARITY: Belongs to the unc-13 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAB15764.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=UNC13Dbase; Note=UNC13D mutation db;
CC       URL="http://structure.bmc.lu.se/idbase/UNC13Dbase/";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ578444; CAE17516.1; -; mRNA.
DR   EMBL; AK024474; BAB15764.1; ALT_INIT; mRNA.
DR   EMBL; AK301529; BAG63031.1; -; mRNA.
DR   EMBL; AC087289; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC067084; AAH67084.1; -; mRNA.
DR   CCDS; CCDS11730.1; -. [Q70J99-1]
DR   RefSeq; NP_954712.1; NM_199242.2. [Q70J99-1]
DR   AlphaFoldDB; Q70J99; -.
DR   SMR; Q70J99; -.
DR   BioGRID; 128383; 24.
DR   IntAct; Q70J99; 3.
DR   STRING; 9606.ENSP00000207549; -.
DR   GlyCosmos; Q70J99; 1 site, 2 glycans.
DR   GlyGen; Q70J99; 1 site, 2 O-linked glycans (1 site).
DR   iPTMnet; Q70J99; -.
DR   MetOSite; Q70J99; -.
DR   PhosphoSitePlus; Q70J99; -.
DR   BioMuta; UNC13D; -.
DR   DMDM; 51316668; -.
DR   EPD; Q70J99; -.
DR   jPOST; Q70J99; -.
DR   MassIVE; Q70J99; -.
DR   MaxQB; Q70J99; -.
DR   PaxDb; Q70J99; -.
DR   PeptideAtlas; Q70J99; -.
DR   ProteomicsDB; 68558; -. [Q70J99-1]
DR   ProteomicsDB; 68559; -. [Q70J99-2]
DR   ProteomicsDB; 68560; -. [Q70J99-3]
DR   Antibodypedia; 32273; 243 antibodies from 36 providers.
DR   DNASU; 201294; -.
DR   Ensembl; ENST00000207549.9; ENSP00000207549.3; ENSG00000092929.13. [Q70J99-1]
DR   Ensembl; ENST00000412096.6; ENSP00000388093.1; ENSG00000092929.13. [Q70J99-3]
DR   GeneID; 201294; -.
DR   KEGG; hsa:201294; -.
DR   MANE-Select; ENST00000207549.9; ENSP00000207549.3; NM_199242.3; NP_954712.1.
DR   UCSC; uc002jpp.5; human. [Q70J99-1]
DR   AGR; HGNC:23147; -.
DR   CTD; 201294; -.
DR   DisGeNET; 201294; -.
DR   GeneCards; UNC13D; -.
DR   GeneReviews; UNC13D; -.
DR   HGNC; HGNC:23147; UNC13D.
DR   HPA; ENSG00000092929; Tissue enhanced (bone marrow, lymphoid tissue).
DR   MalaCards; UNC13D; -.
DR   MIM; 608897; gene.
DR   MIM; 608898; phenotype.
DR   neXtProt; NX_Q70J99; -.
DR   OpenTargets; ENSG00000092929; -.
DR   Orphanet; 540; Familial hemophagocytic lymphohistiocytosis.
DR   PharmGKB; PA134919958; -.
DR   VEuPathDB; HostDB:ENSG00000092929; -.
DR   eggNOG; KOG1328; Eukaryota.
DR   GeneTree; ENSGT00730000110939; -.
DR   HOGENOM; CLU_003295_1_0_1; -.
DR   InParanoid; Q70J99; -.
DR   OMA; ICKTKAF; -.
DR   OrthoDB; 3059697at2759; -.
DR   PhylomeDB; Q70J99; -.
DR   TreeFam; TF315526; -.
DR   PathwayCommons; Q70J99; -.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   SignaLink; Q70J99; -.
DR   BioGRID-ORCS; 201294; 24 hits in 1159 CRISPR screens.
DR   ChiTaRS; UNC13D; human.
DR   GeneWiki; UNC13D; -.
DR   GenomeRNAi; 201294; -.
DR   Pharos; Q70J99; Tbio.
DR   PRO; PR:Q70J99; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   RNAct; Q70J99; protein.
DR   Bgee; ENSG00000092929; Expressed in granulocyte and 132 other tissues.
DR   ExpressionAtlas; Q70J99; baseline and differential.
DR   Genevisible; Q70J99; HS.
DR   GO; GO:0035578; C:azurophil granule lumen; TAS:Reactome.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0070382; C:exocytic vesicle; IDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0005770; C:late endosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0005764; C:lysosome; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0055037; C:recycling endosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0033093; C:Weibel-Palade body; IDA:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0031267; F:small GTPase binding; IDA:UniProtKB.
DR   GO; GO:0051607; P:defense response to virus; IEA:Ensembl.
DR   GO; GO:0002467; P:germinal center formation; IEA:Ensembl.
DR   GO; GO:0002432; P:granuloma formation; IEA:Ensembl.
DR   GO; GO:0043320; P:natural killer cell degranulation; IEA:Ensembl.
DR   GO; GO:0006909; P:phagocytosis; IEA:Ensembl.
DR   GO; GO:0045921; P:positive regulation of exocytosis; IMP:UniProtKB.
DR   GO; GO:1903307; P:positive regulation of regulated secretory pathway; IGI:UniProtKB.
DR   GO; GO:1900026; P:positive regulation of substrate adhesion-dependent cell spreading; IEA:Ensembl.
DR   GO; GO:0043304; P:regulation of mast cell degranulation; IMP:UniProtKB.
DR   GO; GO:0046903; P:secretion; IBA:GO_Central.
DR   CDD; cd08676; C2A_Munc13-like; 1.
DR   CDD; cd04009; C2B_Munc13-like; 1.
DR   Gene3D; 1.10.357.50; -; 1.
DR   Gene3D; 1.20.58.1100; -; 1.
DR   Gene3D; 2.60.40.150; C2 domain; 2.
DR   InterPro; IPR000008; C2_dom.
DR   InterPro; IPR035892; C2_domain_sf.
DR   InterPro; IPR010439; MUN_dom.
DR   InterPro; IPR014770; Munc13_1.
DR   InterPro; IPR014772; Munc13_dom-2.
DR   PANTHER; PTHR45999:SF3; PROTEIN UNC-13 HOMOLOG D; 1.
DR   PANTHER; PTHR45999; UNC-13-4A, ISOFORM B; 1.
DR   Pfam; PF00168; C2; 2.
DR   Pfam; PF06292; MUN; 1.
DR   SMART; SM00239; C2; 2.
DR   SUPFAM; SSF49562; C2 domain (Calcium/lipid-binding domain, CaLB); 2.
DR   PROSITE; PS50004; C2; 2.
DR   PROSITE; PS51258; MHD1; 1.
DR   PROSITE; PS51259; MHD2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Calcium; Cytoplasm; Endosome; Exocytosis;
KW   Familial hemophagocytic lymphohistiocytosis; Lysosome; Membrane;
KW   Metal-binding; Phosphoprotein; Reference proteome; Repeat.
FT   CHAIN           1..1090
FT                   /note="Protein unc-13 homolog D"
FT                   /id="PRO_0000188581"
FT   DOMAIN          92..239
FT                   /note="C2 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   DOMAIN          557..677
FT                   /note="MHD1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00587"
FT   DOMAIN          788..895
FT                   /note="MHD2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00588"
FT   DOMAIN          910..1035
FT                   /note="C2 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   REGION          240..543
FT                   /note="Interaction with RAB27A"
FT   REGION          1026..1048
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         127
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   BINDING         133
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   BINDING         206
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   BINDING         208
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   BINDING         940
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   BINDING         941
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   BINDING         941
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   BINDING         947
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   BINDING         1005
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   BINDING         1005
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   BINDING         1007
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   BINDING         1007
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   BINDING         1013
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   MOD_RES         150
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648"
FT   VAR_SEQ         286
FT                   /note="R -> RVGRVLGQWPCPALAAVCWVAGLAAPSVRPCLLTEASLQ (in
FT                   isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:11214971"
FT                   /id="VSP_011385"
FT   VAR_SEQ         318..325
FT                   /note="AGSTSWDG -> VLPSWGWA (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:11214971"
FT                   /id="VSP_011386"
FT   VAR_SEQ         326..1090
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:11214971"
FT                   /id="VSP_011387"
FT   VAR_SEQ         1081..1090
FT                   /note="ASQHALRPAP -> GIGPSVSWPWPICLLAFLFQPLGWGPGSLGPGLQAQSL
FT                   LEKGEGTLPKMRLQLPWGEGGGHY (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_037949"
FT   VARIANT         59
FT                   /note="A -> T (in dbSNP:rs9904366)"
FT                   /id="VAR_052469"
FT   VARIANT         858
FT                   /note="H -> Q (in dbSNP:rs17496835)"
FT                   /id="VAR_029771"
FT   VARIANT         867
FT                   /note="K -> E (in dbSNP:rs1135688)"
FT                   /id="VAR_029772"
FT   MUTAGEN         608..611
FT                   /note="Missing: Abolishes localization to lysosomes and
FT                   interaction with RAB27A."
FT                   /evidence="ECO:0000269|PubMed:15548590"
FT   CONFLICT        137
FT                   /note="L -> P (in Ref. 3; BAG63031)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        476
FT                   /note="H -> R (in Ref. 3; BAG63031)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        590
FT                   /note="Q -> R (in Ref. 3; BAG63031)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        796
FT                   /note="K -> E (in Ref. 3; BAG63031)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1090 AA;  123282 MW;  A71AD7A4E32C940C CRC64;
     MATLLSHPQQ RPPFLRQAIK IRRRRVRDLQ DPPPQMAPEI QPPSHHFSPE QRALLYEDAL
     YTVLHRLGHP EPNHVTEASE LLRYLQEAFH VEPEEHQQTL QRVRELEKPI FCLKATVKQA
     KGILGKDVSG FSDPYCLLGI EQGVGVPGGS PGSRHRQKAV VRHTIPEEET HRTQVITQTL
     NPVWDETFIL EFEDITNASF HLDMWDLDTV ESVRQKLGEL TDLHGLRRIF KEARKDKGQD
     DFLGNVVLRL QDLRCREDQW YPLEPRTETY PDRGQCHLQF QLIHKRRATS ASRSQPSYTV
     HLHLLQQLVS HEVTQHEAGS TSWDGSLSPQ AATVLFLHAT QKDLSDFHQS MAQWLAYSRL
     YQSLEFPSSC LLHPITSIEY QWIQGRLKAE QQEELAASFS SLLTYGLSLI RRFRSVFPLS
     VSDSPARLQS LLRVLVQMCK MKAFGELCPN TAPLPQLVTE ALQTGTTEWF HLKQQHHQPM
     VQGIPEAGKA LLGLVQDVIG DLHQCQRTWD KIFHNTLKIH LFSMAFRELQ WLVAKRVQDH
     TTVVGDVVSP EMGESLFQLY ISLKELCQLR MSSSERDGVL ALDNFHRWFQ PAIPSWLQKT
     YNEALARVQR AVQMDELVPL GELTKHSTSA VDLSTCFAQI SHTARQLDWP DPEEAFMITV
     KFVEDTCRLA LVYCSLIKAR ARELSSGQKD QGQAANMLCV VVNDMEQLRL VIGKLPAQLA
     WEALEQRVGA VLEQGQLQNT LHAQLQSALA GLGHEIRTGV RTLAEQLEVG IAKHIQKLVG
     VRESVLPEDA ILPLMKFLEV ELCYMNTNLV QENFSSLLTL LWTHTLTVLV EAAASQRSSS
     LASNRLKIAL QNLEICFHAE GCGLPPKALH TATFQALQRD LELQAASSRE LIRKYFCSRI
     QQQAETTSEE LGAVTVKASY RASEQKLRVE LLSASSLLPL DSNGSSDPFV QLTLEPRHEF
     PELAARETQK HKKDLHPLFD ETFEFLVPAE PCRKAGACLL LTVLDYDTLG ADDLEGEAFL
     PLREVPGLSG SEEPGEVPQT RLPLTYPAPN GDPILQLLEG RKGDREAQVF VRLRRHRAKQ
     ASQHALRPAP
//
